Although complete loss-of-function mutations in the PTEN gene are often lethal or result in severe syndromic conditions such as PTEN hamartoma tumor syndrome (PHTS), even a partial reduction in PTEN function, most commonly through haploinsufficiency, can have substantial clinical consequences [56]. This evidence concerns the gene PTEN and PTEN hamartoma tumor syndrome.